SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-103794
Filing Date
2020-04-10
Accepted
2020-04-10 16:06:03
Documents
6
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A d893762dpre14a.htm PRE 14A 602733
2 GRAPHIC g893762g10k52.jpg GRAPHIC 52708
3 GRAPHIC g893762g10p85.jpg GRAPHIC 44273
4 GRAPHIC g893762g15k66.jpg GRAPHIC 53304
5 GRAPHIC g893762pc1.jpg GRAPHIC 158470
6 GRAPHIC g893762pc2.jpg GRAPHIC 119508
  Complete submission text file 0001193125-20-103794.txt   1187443
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36352 | Film No.: 20786817
SIC: 2834 Pharmaceutical Preparations